Hints and tips:
Related Special Reports
...Clarifying which companies are responsible for innovations will be “even more important” as pharma companies explore uses for mRNA in cancer, autoimmune diseases and other viruses, said Anna Wolters-Höhne...
...“We would acknowledge that this is not going to be some sort of a V-shaped recovery. There are going to be plenty of troubled deals in the market,” added Gray....
...The broker also alleged that Alcan had deleted text messages after the company launched an investigation....
...The Knoxville-based company is the largest business of its kind in America with more than 750 locations in the US and Canada and 30,000 employees....
...On a conference call with analysts in January, Gray said Breit had “weathered the storm” in real estate markets, but he warned that Blackstone did not expect to see a “V-sharped recovery” in property values...
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
...Claudia Gray, head of financial sector research at ShareAction, said it was the “worst result we’ve seen from asset managers in recent years”, and “deeply concerning”....
...But, of course, there’s a reason why it’s widely called Shitibank; the sprawling, gormless Citi has for a v v v very long time proven adept at blithely ambling onto various rakes around the world....
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...Merck’s lawsuit is the first by a major drug company, but analysts predict others are likely to follow its lead and sue the government ahead of the full implementation of the drug price negotiation elements...
...Yet Merck recorded sales worth more than $6bn between 2021 and 2022, and the figure does not include sales in poorer markets where licensed companies make generic versions of the drug....
...Yet the company’s monoclonal antibody treatment for inflammatory bowel disease has yet to be fully approved....
...Its companies have combined annual revenues of $75bn and 115,000 employees....
...Before most people knew what a camera was, the V&A was already amassing photographs....
...Merck said the deal would strengthen the company’s position in the fast-growing field of immunology, where there is significant unmet patient need....
...We’re trying to invest right across the creative sector, across a wide range of entertainment sectors, in high-growth companies.”...
...Blackstone’s president Jonathan Gray earlier this year said it was a “golden moment” for the fast-growing $1.5tn industry....
...Simon Mawhinney, chief investment officer at Allan Gray Australia, which owns a 3.5 per cent stake in Origin, said his fund would vote in favour....
...Merck called for the UK government to do more to support the pharma industry as it opened a £1bn research centre in London....
...the crisp company....
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
...Implementing the proposals could undermine the company’s core business model, said Merck in response to a proposal made by The Capuchin Franciscan Province of St. Joseph....
...Merck was in talks last summer to acquire Seagen for about $200 a share, or $40bn. But negotiations ended after the two failed to agree on price....
International Edition